scispace - formally typeset
Search or ask a question

How long can you live without a kidney transplant? 

Nephrology
Kidney disease
Kidney
Kidney transplantation
Transplantation

Answers from top 9 papers

More filters
Papers (9)Insight
Open access•Journal Article•DOI
Lifetime risks of kidney donation: a medical decision analysis
Bryce A. Kiberd, Karthik K. Tennankore 
01 Aug 2017-BMJ Open
14 Citations
Live kidney donation may reduce life expectancy by 0.5–1 year in most donors.
Journal Article•DOI
Renal Disease in Recipients of Nonrenal Solid Organ Transplantation
Akinlolu O. Ojo
01 Jul 2007-Seminars in Nephrology
100 Citations
Compared with maintenance dialysis, kidney transplantation reduces long-term mortality by 60% to 70% in nonrenal transplant recipients with end-stage renal disease.
Journal Article•DOI
Pancreas-after-kidney transplantation: to have and not have not.
Dixon B. Kaufman
01 Aug 2009-Clinical Transplantation
13 Citations
Thus, in the situation where the waiting time for a SPK is relatively long, uremic diabetics fortunate enough to have a LD for a kidney transplant can avoid dialysis and also receive a deceased donor PAK transplant three or more months later.
Open access•Journal Article•DOI
Renal transplantation in the elderly: a long‐term, single‐centre experience
Patrick Saudan, Thierry Berney, Michel Leski, Philippe Morel, Jean François Bolle, Pierre-Yves Martin 
01 Apr 2001-Nephrology Dialysis Transplantation
62 Citations
Although these patients have a shorter life expectancy, they benefit from renal transplantation similarly to younger kidney transplant recipients.
Journal Article•DOI
Long-term results of renal transplant from living donors aged over 60 years.
Gongbin Lan, Luoyan Yang, Longkai Peng, Fenghua Peng, Yu Wang, Shaojie Yu, Xubiao Xie 
26 Apr 2012-Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
6 Citations
Our studies suggest that in the long term, renal transplant from live donors older than 60 years it is an acceptable alternative.
Journal Article•DOI
Pediatric kidney transplantation: a snapshot 10 years later.
Mariano Ferraresso, Luciana Ghio, M. Raiteri, Mirco Belingheri, C. Beretta, Valentina Martina, Alberto Edefonti, Luisa Berardinelli 
01 Jul 2008
6 Citations
In conclusion, long-term survivors of a kidney transplant received during childhood reached a high degree of rehabilitation despite a long period of immunosuppression.
Journal Article•DOI
Immunologic factors: the major risk for decreased long-term renal allograft survival.
Abhinav Humar, A. Hassoun, Raja Kandaswamy, William D. Payne, David E.R. Sutherland, Arthur J. Matas 
27 Dec 1999-Transplantation
93 Citations
This very low incidence of chronic rejection in recipients without previous AR suggests that immunologic factors are the main determinants of long-term kidney transplant outcome; nonimmunologic factors in isolation may have only a minimal impact on long-term graft survival.
Open access•Journal Article•DOI
Impact of Graft Mass on the Clinical Outcome of Kidney Transplants
Magali Giral, Jean Michel Nguyen, Georges Karam, M. Kessler, Bruno Hurault de Ligny, Mattias Buchler, François Bayle, Carole Meyer, Yohann Foucher, Marie Laure Martin, Pascal Daguin, Jean-Paul Soulillou 
01 Dec 2004-Journal of The American Society of Nephrology
80 Citations
Avoiding major kidney/recipient inadequacy should have a significant influence on long-term transplant function.
Open access•Journal Article•DOI
Comparing Three Data Mining Methods to Predict Kidney Transplant Survival
Leila Shahmoradi, Mostafa Langarizadeh, Gholamreza Pourmand, Ziba Aghsaei Fard, Alireza Borhani 
01 Oct 2016-Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : časopis Društva za medicinsku informatiku BiH
23 Citations
The most effective kidney transplant survival factors were detected in this study; therefore, duration of transplant survival (year) can be determined considering the regulations set for a new sample with specific characteristics.

Related Questions

How many years living after living kidney transplant?5 answersLiving kidney transplant recipients have shown long-term graft survival, with some recipients achieving graft survival of ≥50 years. In one study, the overall graft survival rate was observed to be >80% after 13 years. Another study reported that living kidney donors who donated ≥50 years ago had a mean estimated glomerular filtration rate (eGFR) of 60.2 ± 13.4 mL/min/1.73 m2 for donors currently alive. Additionally, the median survival for living kidney donor transplants increased from 12.1 years in 1995-1999 to an estimated 19.2 years for transplants in 2014-2017. These findings suggest that living kidney transplant recipients can experience long-term survival, with some recipients achieving graft survival for ≥50 years, and improvements in graft survival rates over time.
How many years on average do patients live after a living kidney transplant?5 answersOn average, patients live for more than 50 years after a living kidney transplant.
Can you live without a spleen if you have cirrhosis?5 answers
Can you live without motor neurons?7 answers
How long can you live without thyroid cancer treatment?3 answers
What celebrity has had a kidney transplant?10 answers

See what other people are reading

What are the specific hormonal and mineral imbalances associated with hyperparathyroidism?
5 answers
Hyperparathyroidism is characterized by hormonal and mineral imbalances. In primary hyperparathyroidism (PHPT), there is hypersecretion of parathyroid hormone (PTH), leading to hypercalcemia and relative hypophosphatemia. On the other hand, secondary hyperparathyroidism in chronic kidney disease (CKD) results from increased iPTH secretion due to disrupted calcium-phosphorus-vitamin D axis, exacerbating with vitamin D deficiency. PTH actions include promoting calcium release from bone, renal calcium reabsorption, and phosphate excretion. These imbalances can lead to complications like bony demineralization, nephrolithiasis, and hypercalcemic crisis in PHPT, while CKD-related hyperparathyroidism contributes to vascular calcification and cardiac mortality. Therefore, understanding these hormonal and mineral disturbances is crucial for managing hyperparathyroidism effectively.How does the presence of snakehead fish in hemodialysis systems affect the quality of life for patients undergoing treatment?
5 answers
The presence of snakehead fish in hemodialysis systems does not directly impact the quality of life for patients undergoing treatment. Research has focused on factors like economic status, comorbidities, fish oil supplementation, lifestyle changes, and sleep quality in hemodialysis patients. Studies have shown that economic status and the number of comorbid factors can influence quality of life. Fish oil intake has been found to reduce protein-energy wasting, improve physical and biochemical parameters, and enhance quality of life in hemodialysis patients. Lifestyle changes associated with hemodialysis treatment can affect mental, psychological, and social aspects of patients. Additionally, omega-3 supplementation has been linked to improved sleep quality in hemodialysis patients, ultimately impacting their overall quality of life positively.What is the best DOACs for patient with renal failure?
5 answers
Among patients with renal failure, Apixaban is considered the best Direct Oral Anticoagulant (DOAC). Studies have shown that Apixaban outperforms other anticoagulants like warfarin in terms of safety and effectiveness, making it the top-ranked option for patients with renal insufficiency. Additionally, the pleiotropic effects of DOACs, including vascular protection and anti-inflammatory properties, along with their comparable efficacy and safety to VKAs, support the preference for DOACs like Apixaban in patients with chronic kidney disease. Furthermore, the use of DOACs in patients with non-end stage kidney disease and atrial fibrillation has shown effectiveness similar to warfarin but with a better safety profile. Therefore, Apixaban stands out as the optimal choice for patients with renal failure requiring anticoagulation therapy.Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
5 answers
Canagliflozin, a sodium-glucose co-transporter 2 inhibitor, has shown promising results in improving renal outcomes in patients with type 2 diabetes and kidney disease. The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) trial demonstrated significant nephroprotection by reducing the risk of end-stage kidney disease, doubling of serum creatinine, and renal or cardiovascular death. Specifically, in East and South-East Asian countries, where participants are at high risk of renal complications, canagliflozin significantly lowered the risk of primary renal outcomes. These findings support the approval of canagliflozin for treating diabetic kidney disease, marking a significant advancement in renal care for patients with type 2 diabetes.How does astorvastatin work to reduce hyperlipidaemia?
5 answers
Atorvastatin works to reduce hyperlipidemia through various mechanisms. It alters the intestinal microbiome, increasing the abundance of beneficial bacteria like Bacteroides, which improves metabolic pathways related to lipid reduction. Additionally, atorvastatin inhibits the enzyme HMG-CoA reductase, reducing cholesterol synthesis in the liver. It also affects endothelial function by enhancing nitric oxide (NO) production and decreasing harmful superoxide radicals, potentially improving cardiovascular health. In patients with chronic renal disease, atorvastatin safely lowers total cholesterol and LDL cholesterol levels, contributing to the prevention of renal disease progression. Furthermore, in clinical trials, atorvastatin has consistently shown a reduction in stroke risk, making it a valuable agent in both primary and secondary prevention of cerebrovascular disease.What are the potential long-term effects of using snakehead fish in hemodialysis treatment on patient health outcomes?
5 answers
The use of different types of fish in hemodialysis treatment can have varying effects on patient health outcomes. Fish oil, rich in omega-3 fatty acids, has shown benefits in hemodialysis patients by reducing protein-energy wasting, improving physical parameters, and enhancing quality of life. However, it is essential to consider potential drawbacks, such as the presence of trimethylamine N-oxide (TMAO) in fish, which is a uremic toxin associated with increased cardiovascular risk in chronic kidney disease patients. On the other hand, catfish abon, a nutritional support derived from catfish, has been linked to increased creatinine levels in hemodialysis patients, indicating a potential negative impact on kidney function. Therefore, while fish oil may offer benefits, the choice of fish and its preparation in hemodialysis treatment should be carefully considered to optimize patient outcomes.How high blood pressure causes atherosclerosis?
4 answers
High blood pressure (BP) contributes to atherosclerosis through various mechanisms. Elevated BP, even within the high-normal range, is associated with increased cardiovascular risk. Hypertension leads to vascular inflammation, which is a key link between high BP levels and atherosclerosis development. Additionally, hypertension causes alterations in vascular reactivity, hypertrophy, and fibrosis, promoting atherosclerosis progression. BP variability may also play a role in initiating atherosclerosis by affecting vessel wall tension and shear stress. Cumulative high BP levels over time are significant risk factors for atherosclerosis and cardiovascular disease progression. These findings underscore the importance of controlling BP to prevent atherosclerosis and its associated complications.COmplication of hemothorax treatment ?
4 answers
Complications of hemothorax treatment can vary depending on the underlying cause and management approach. Spontaneous hemothorax related to anticoagulant therapy, such as apixaban, is a rare but serious complication. Surgical intervention may be necessary in cases of penetrating chest injuries with significant blood volume in the pleural cavity. In liver transplant recipients, postoperative hemothorax, often iatrogenic, can lead to thoracic complications and a high mortality rate, emphasizing the need for preventive measures. Older adults with rib fractures may experience delayed progression of hemothoraces, potentially leading to delayed diagnosis and treatment. Monitoring for complications like empyema, fibrothorax, and the need for late secondary thoracotomy is crucial in hemothorax management. Vigilance in monitoring and prompt intervention are essential to mitigate the risks associated with hemothorax treatment.How hypertension cause kidney disease?
5 answers
Hypertension plays a significant role in the development and progression of kidney disease by inducing microvascular and macrovascular damage. In chronic kidney disease (CKD), hypertension is a common comorbidity that can exacerbate renal dysfunction. The interplay between hypertension and CKD involves mechanisms such as reduced nephron mass, sympathetic nervous system overactivation, renin-angiotensin-aldosterone system involvement, and endothelial dysfunction. Poorly controlled hypertension can lead to deteriorating renal function, while CKD itself can contribute to worsening hypertension, creating a vicious cycle. Effective management strategies for hypertensive kidney disease include targeting blood pressure control through interventions like RAAS antagonists, renal nerve denervation, and baroreflex stimulation. Controlling hypertension is crucial in preventing the progression of kidney disease and reducing the associated cardiovascular burden.How to diagnose acute kidney injury in mouse models?
10 answers
Diagnosing acute kidney injury (AKI) in mouse models involves a multifaceted approach that leverages both traditional and innovative techniques to assess renal function and detect injury markers. Immunofluorescence staining, as described by Chowdhury et al., allows for the spatial analysis of heterogeneous injury responses, which deep learning tools can quantify, offering insights into the evolution of kidney injury and repair mechanisms. Similarly, the use of positron emission tomography (PET) with 68Ga-Ethylenediaminetetraacetic acid (68Ga-EDTA) as a tracer has been shown to provide a reliable and precise means of evaluating renal function, capable of differentiating between healthy and injured kidneys in mouse models. Another innovative approach involves the use of genetically modified mice to detect acute responses to kidney injury through the tagging of nascent RNA, enabling the identification of stimulus-specific, cell-specific, and time-dependent responses. Near-infrared (NIR) fluorescent imaging probes targeting biomarkers of apoptosis have also been developed, allowing for the early detection of AKI and monitoring of kidney function recovery. Research has highlighted the importance of developing personalized human-based models, including human stem cells and organoids, to better understand and diagnose AKI, suggesting a potential future direction for AKI diagnostics. The identification of specific biomarkers and hub genes related to drug-induced AKI further enhances the diagnostic toolkit, offering targets for early detection and therapeutic intervention. Spatial transcriptomic sequencing has emerged as a powerful tool to map gene expression across injury and repair time courses, providing a comprehensive view of cellular interactions and responses to injury. Studies across diverse mouse strains have revealed strain-specific responses to kidney injury, underscoring the importance of genetic background in AKI diagnosis and research. Functional MRI techniques, including T2-mapping and diffusion-weighted imaging, have been employed to characterize edema formation and inflammation, offering non-invasive diagnostic markers. Lastly, DNA nanomachines targeting specific biomarkers like Kim-1 have shown promise for the early diagnosis of AKI, demonstrating the potential for nanotechnology in enhancing AKI diagnostics. Together, these studies illustrate the complexity of diagnosing AKI in mouse models and highlight the integration of traditional and cutting-edge technologies to improve diagnostic accuracy and understanding of the disease.How to check Treg function?
5 answers
To check Treg function, various methods are employed. One approach involves assessing the differential methylation pattern of the FOXP3 Treg-specific demethylation region (TSDR) using a droplet digital PCR assay, which can quantitatively monitor nTreg expansion in vitro. Another method includes culturing Treg cells in the presence of inflammatory cytokines like IL-6 to evaluate their stability, activity, and suppressive function, with a focus on measuring FoxP3 expression levels and T-effector cell proliferation suppression. Additionally, reliable identification of human Tregs often involves combined assessment of phenotypic, epigenetic, and functional parameters, with in vitro Treg suppression assays being a common practice, albeit with varying methods and readouts. Understanding these diverse approaches is crucial for effectively evaluating Treg function in different experimental and clinical settings.